Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most?

World Journal of Hepatology

Volumn 7, Issue 14, 2015, Pages 1818-1827

  Rodríguez Castro, Kryssia Isabel ^a   Antonello, Alessandro ^a   Ferrarese, Alberto ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Bleeding; Cirrhosis; Coagulation; Hemorrhage; Portal vein thrombosis; Thromboembolism

Indexed keywords

EID: 84937389675     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i14.1818     Document Type: Article

References (109)

1. Huber K, Kirchheimer JC, Korninger C, Binder BR. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis. Thromb Res 1991; 62: 491-500 [PMID: 1910213 DOI: 10.1016/0049-3848(91)90022-O]
2. Simpson AJ, Booth NA, Moore NR, Bennett B. The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease. Br J Haematol 1990; 75: 543-548 [PMID: 2207005 DOI: 10.1111/j.1365-2141.1990.tb07796.x]
3. Leebeek FW, Kluft C, Knot EA, de Maat MP, Wilson JH. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis. Gastroenterology 1991; 101: 1382-1390 [PMID: 1718809]
4. Violi F, Leo R, Basili S, Ferro D, Cordova C, Balsano F. Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study. Haematologica 1994; 79: 61-65 [PMID: 15378950]
5. Páramo JA, Rocha E. Hemostasis in advanced liver disease. Semin Thromb Hemost 1993; 19: 184-190 [PMID: 8362247 DOI: 10.1055/s-2007-994024]
6. Vukovich T, Teufelsbauer H, Fritzer M, Kreuzer S, Knoflach P. Hemostasis activation in patients with liver cirrhosis. Thromb Res 1995; 77: 271-278 [PMID: 7740519 DOI: 10.1016/0049-3848(95)91614-Q]
7. Wilde JT, Kitchen S, Kinsey S, Greaves M, Preston FE. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states. Br J Haematol 1989; 71: 65-70 [PMID: 2917130 DOI: 10.1111/j.1365-2141.1989.tb06276.x]
8. Ben-Ari Z, Osman E, Hutton RA, Burroughs AK. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol 1999; 94: 2977-2982 [PMID: 10520855 DOI: 10.1111/j.1572-0241.1999.01446.x]
9. Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, Gresele P. Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology 2003; 38: 230-237 [PMID: 12830006 DOI: 10.1053/jhep.2003.50277]
10. Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, Sanyal AJ. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 2006; 44: 1039-1046 [PMID: 17006940 DOI: 10.1002/hep.21303]
11. Tripodi A, Primignani M, Mannucci PM. Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged. Intern Emerg Med 2010; 5: 7-12 [PMID: 19714443 DOI: 10.1007/s11739-009-0302-z]
12. Lisman T, Leebeek FW, Mosnier LO, Bouma BN, Meijers JC, Janssen HL, Nieuwenhuis HK, De Groot PG. Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology 2001; 121: 131-139 [PMID: 11438502 DOI: 10.1053/gast.2001.25481]
13. Bennani-Baiti N, Daw HA. Primary hyperfibrinolysis in liver disease: a critical review. Clin Adv Hematol Oncol 2011; 9: 250-252 [PMID: 21475135]
14. Prisco D, Grifoni E. The role of D-dimer testing in patients with suspected venous thromboembolism. Semin Thromb Hemost 2009; 35: 50-59 [PMID: 19308893 DOI: 10.1055/s-0029-1214148]
15. Violi F, Ferro D, Basili S, Quintarelli C, Musca A, Cordova C, Balsano F. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis. Hepatology 1993; 17: 78-83 [PMID: 8423044 DOI: 10.1002/hep.1840170115]
16. Tacke F, Fiedler K, von Depka M, Luedde T, Hecker H, Manns MP, Ganser A, Trautwein C. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease. Liver Int 2006; 26: 173-181 [PMID: 16448455 DOI: 10.1111/j.1478-3231.2005.01205.x]
17. Kłoczko J, Wereszczyńska U, Wojtukiewicz M, Gybryelewicz A, Bielawiec M. Fibrin stabilization, factor XIII transamidase activity and subunits "A" and "B" concentration in plasma of patients with liver cirrhosis. Folia Haematol Int Mag Klin Morphol Blutforsch 1986; 113: 539-544 [PMID: 2431976]
18. Saner FH, Gieseler RK, Aki{dotless}z H, Canbay A, Görlinger K. Delicate balance of bleeding and thrombosis in end-stage liver disease and liver transplantation. Digestion 2013; 88: 135-144 [PMID: 24008288 DOI: 10.1159/000354400]
19. LaffiG, Marra F, Gresele P, Romagnoli P, Palermo A, Bartolini O, Simoni A, Orlandi L, Selli ML, Nenci GG. Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 1992; 103: 641-646 [PMID: 1386051]
20. Peck-Radosavljevic M. Thrombocytopenia in liver disease. Can J Gastroenterol 2000; 14 Suppl D: 60D-66D [PMID: 11110614]
21. Ordinas A, Escolar G, Cirera I, Viñas M, Cobo F, Bosch J, Terés J, Rodés J. Existence of a platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions. Hepatology 1996; 24: 1137-1142 [PMID: 8903388 DOI: 10.1053/jhep.1996.v24.pm0008903388]
22. Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, Burroughs AK. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 1999; 44: 754-758 [PMID: 10205219 DOI: 10.1136/gut.44.5.754]
23. Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology 2006; 44: 53-61 [PMID: 16799972 DOI: 10.1002/hep.21231]
24. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Iannaccone L, D'Andrea G, Marmo R, Ames PR, Balzano A. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000; 31: 345-348 [PMID: 10655256 DOI: 10.1002/hep.510310213]
25. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45: 1413-1425 [PMID: 16131373 DOI: 10.1111/j.1537-2995.2005.00546.x]
26. Blake JC, Sprengers D, Grech P, McCormick PA, McIntyre N, Burroughs AK. Bleeding time in patients with hepatic cirrhosis. BMJ 1990; 301: 12-15 [PMID: 2383699 DOI: 10.1136/bmj.301.6742.12]
27. Violi F, Leo R, Vezza E, Basili S, Cordova C, Balsano F. Bleeding time in patients with cirrhosis: relation with degree of liver failure and clotting abnormalities. C.A.L.C. Group. Coagulation Abnormalities in Cirrhosis Study Group. J Hepatol 1994; 20: 531-536 [PMID: 8051393 DOI: 10.1016/S0168-8278(05)80501-X]
28. Lisman T, Bakhtiari K, Pereboom IT, Hendriks HG, Meijers JC, Porte RJ. Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests. J Hepatol 2010; 52: 355-361 [PMID: 20132999 DOI: 10.1016/j.jhep.2009.12.001]
29. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, Mannuccio Mannucci P. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41: 553-558 [PMID: 15726661 DOI: 10.1002/hep.20569]
30. Saxena P, Bihari C, Rastogi A, Agarwal S, Anand L, Sarin SK. Sonoclot signature analysis in patients with liver disease and its correlation with conventional coagulation studies. Adv Hematol 2013; 2013: 237351 [PMID: 24396346 DOI: 10.1155/2013/237351]
31. Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106: 1366-1375 [PMID: 18420846 DOI: 10.1213/ane.0b013e318168b367]
32. Lisman T, Porte RJ, Leebeek FW, Caldwell SH. Methodological issues with coagulation testing in patients with liver disease. J Thromb Haemost 2006; 4: 2061-2062 [PMID: 16961614 DOI: 10.1111/j.1538-7836.2006.02076.x]
33. Lang T, Johanning K, Metzler H, Piepenbrock S, Solomon C, Rahe-Meyer N, Tanaka KA. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 2009; 108: 751-758 [PMID: 19224779 DOI: 10.1213/ane.0b013e3181966675]
34. Tripodi A. Tests of coagulation in liver disease. Clin Liver Dis 2009; 13: 55-61 [PMID: 19150309 DOI: 10.1016/j.cld.2008.09.002]
35. Rijken DC, Kock EL, Guimarães AH, Talens S, Darwish Murad S, Janssen HL, Leebeek FW. Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests. J Thromb Haemost 2012; 10: 2116-2122 [PMID: 22906184 DOI: 10.1111/j.1538-7836.2012.04901.x]
36. Krzanicki D, Sugavanam A, Mallett S. Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography. Liver Transpl 2013; 19: 852-861 [PMID: 23696318 DOI: 10.1002/lt.23668]
37. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001; 12: 327-337 [PMID: 11505075 DOI: 10.1097/00001721-200107000-00001]
38. Wang SC, Shieh JF, Chang KY, Chu YC, Liu CS, Loong CC, Chan KH, Mandell S, Tsou MY. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc 2010; 42: 2590-2593 [PMID: 20832550 DOI: 10.1016/j.transproceed.2010.05.144]
39. Ben-Ari Z, Panagou M, Patch D, Bates S, Osman E, Pasi J, Burroughs A. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol 1997; 26: 554-559 [PMID: 9075662 DOI: 10.1016/S0168-8278(97)80420-5]
40. Senzolo M, Cholongitas E, Thalheimer U, Riddell A, Agarwal S, Mallett S, Ferronato C, Burroughs AK. Heparin-like effect in liver disease and liver transplantation. Clin Liver Dis 2009; 13: 43-53 [PMID: 19150308 DOI: 10.1016/j.cld.2008.09.004]
41. Chau TN, Chan YW, Patch D, Tokunaga S, Greenslade L, Burroughs AK. Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut 1998; 43: 267-271 [PMID: 10189856 DOI: 10.1136/gut.43.2.267]
42. De Pietri L, Bianchini M, Montalti R, De Maria N, Di Maira T, Begliomini B, Gerunda G, Villa E. Thrombelastography (TEG) decreases blood products requirement before invasive procedures in cirrhotic patients with coagulation tests derangement. A randomized controlled trial. Dig Liver Dis 2014; 46: e5-e6 [DOI: 10.1016/j.dld.2014.01.017]
43. Bendtsen F, D'Amico G, Rusch E, de Franchis R, Andersen PK, Lebrec D, Thabut D, Bosch J. Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials. J Hepatol 2014; 61: 252-259 [PMID: 24713188 DOI: 10.1016/j.jhep.2014.03.035]
44. Villanueva C, Piqueras M, Aracil C, Gómez C, López-Balaguer JM, Gonzalez B, Gallego A, Torras X, Soriano G, Sáinz S, Benito S, Balanzó J. A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding. J Hepatol 2006; 45: 560-567 [PMID: 16904224 DOI: 10.1016/j.jhep.2006.05.016]
45. Abraldes JG, Villanueva C, Bañares R, Aracil C, Catalina MV, Garci A-Pagán JC, Bosch J. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008; 48: 229-236 [PMID: 18093686 DOI: 10.1016/j.jhep.2007.10.008]
46. Jairath V, Rehal S, Logan R, Kahan B, Hearnshaw S, Stanworth S, Travis S, Murphy M, Palmer K, Burroughs A. Acute variceal haemorrhage in the United Kingdom: patient characteristics, management and outcomes in a nationwide audit. Dig Liver Dis 2014; 46: 419-426 [PMID: 24433997 DOI: 10.1016/j.dld.2013.12.010]
47. Groszmann RJ, Bosch J, Grace ND, Conn HO, Garcia-Tsao G, Navasa M, Alberts J, Rodes J, Fischer R, Bermann M. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990; 99: 1401-1407 [PMID: 2210246]
48. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, Garcia-Pagan JC, Patch D, MatloffDS, Gao H, Makuch R. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005; 353: 2254-2261 [PMID: 16306522 DOI: 10.1097/01.sa.0000234709.37860.e7]
49. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006; 131: 1611-1624 [PMID: 17101332 DOI: 10.1053/j.gastro.2006.09.013]
50. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5: 419-424 [PMID: 3873388 DOI: 10.1002/hep.1840050313]
51. Villa E, Cammà C, Marietta M, Luongo M, Critelli R, Colopi S, Tata C, Zecchini R, Gitto S, Petta S, Lei B, Bernabucci V, Vukotic R, De Maria N, Schepis F, Karampatou A, Caporali C, Simoni L, Del Buono M, Zambotto B, Turola E, Fornaciari G, Schianchi S, Ferrari A, Valla D. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology 2012; 143: 1253-1260.e1-4 [PMID: 22819864 DOI: 10.1053/j.gastro.2012.07.018]
52. Zambruni A, Thalheimer U, Coppell J, Riddell A, Mancuso A, Leandro G, Perry D, Burroughs AK. Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and noncirrhotic patients. Scand J Gastroenterol 2004; 39: 830-836 [PMID: 15513380]
53. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999; 353: 139-142 [PMID: 10023916 DOI: 10.1016/S0140-6736(98)06020-6]
54. Goulis J, Armonis A, Patch D, Sabin C, Greenslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998; 27: 1207-1212 [PMID: 9581672 DOI: 10.1002/hep.510270504]
55. Montalto P, Vlachogiannakos J, Cox DJ, Pastacaldi S, Patch D, Burroughs AK. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002; 37: 463-470 [PMID: 12217599 DOI: 10.1016/S0168-8278(02)00208-8]
56. Senzolo M, Coppell J, Cholongitas E, Riddell A, Triantos CK, Perry D, Burroughs AK. The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis 2007; 18: 227-236 [PMID: 17413758 DOI: 10.1097/MBC.0b013e328010bd3d]
57. Hou MC, Lin HC, Liu TT, Kuo BI, Lee FY, Chang FY, Lee SD. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology 2004; 39: 746-753 [PMID: 14999693 DOI: 10.1002/hep.20126]
58. Vieira da Rocha EC, D'Amico EA, Caldwell SH, Flores da Rocha TR, Soares E Silva CS, Dos Santos Bomfim V, Felga G, Barbosa WF, Kassab F, Polli DA, Carrilho FJ, Farias AQ. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. Clin Gastroenterol Hepatol 2009; 7: 988-993 [PMID: 19410018 DOI: 10.1016/j.cgh.2009.04.019]
59. Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, A Burroughs K. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012; 32: 919-927 [PMID: 22435854 DOI: 10.1111/j.1478-3231.2012.02785.x]
60. Bajaj JS, Franco J. Endoscopic band ligation of esophageal varices in patients on anticoagulation. J Clin Gastroenterol 2008; 42: 782-785 [PMID: 18668702 DOI: 10.1097/MCG.0b013e31804bb98b]
61. Venkatesh PG, Parasa S, Njei B, Sanaka MR, Navaneethan U. Increased mortality with peptic ulcer bleeding in patients with both compensated and decompensated cirrhosis. Gastrointest Endosc 2014; 79: 605-614.e3 [PMID: 24119507 DOI: 10.1016/j.gie.2013.08.026]
62. González-González JA, García-Compean D, Vázquez-Elizondo G, Garza-Galindo A, Jáquez-Quintana JO, Maldonado-Garza H. Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of in-hospital mortality. A prospective study. Ann Hepatol 2011; 10: 287-295 [PMID: 21677330]
63. Kim MY, Choi H, Baik SK, Yea CJ, Won CS, Byun JW, Park SY, Kwon YH, Kim JW, Kim HS, Kwon SO, Kim YJ, Cha SH, Chang SJ. Portal hypertensive gastropathy: correlation with portal hypertension and prognosis in cirrhosis. Dig Dis Sci 2010; 55: 3561-3567 [PMID: 20407828 DOI: 10.1007/s10620-010-1221-6]
64. Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, Cestari R, Angeli P, Gatta A, Rossi A, Spinzi G, De Franchis R. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 2000; 119: 181-187 [PMID: 10889167 DOI: 10.1053/gast.2000.8555]
65. Iwao T, Toyonaga A, Sumino M, Takagi K, Oho K, Nishizono M, Ohkubo K, Inoue R, Sasaki E, Tanikawa K. Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology 1992; 102: 2060-2065 [PMID: 1587424]
66. Ripoll C, Garcia-Tsao G. Management of gastropathy and gastric vascular ectasia in portal hypertension. Clin Liver Dis 2010; 14: 281-295 [PMID: 20682235 DOI: 10.1016/j.cld.2010.03.013]
67. Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118: 905-911 [PMID: 10784589 DOI: 10.1016/S0016-5085(00)70176-4]
68. Herrera S, Bordas JM, Llach J, Ginès A, Pellisé M, Fernández-Esparrach G, Mondelo F, Mata A, Cárdenas A, Castells A. The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage. Gastrointest Endosc 2008; 68: 440-446 [PMID: 18423466 DOI: 10.1016/j.gie.2008.02.009]
69. Smith LA, Morris AJ, Stanley AJ. The use of hemospray in portal hypertensive bleeding; a case series. J Hepatol 2014; 60: 457-460 [PMID: 24140803 DOI: 10.1016/j.jhep.2013.10.008]
70. Chen LS, Lin HC, Lee FY, Hou MC, Lee SD. Portal hypertensive colopathy in patients with cirrhosis. Scand J Gastroenterol 1996; 31: 490-494 [PMID: 8734347 DOI: 10.3109/00365529609006770]
71. Ganguly S, Sarin SK, Bhatia V, Lahoti D. The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology 1995; 21: 1226-1231 [PMID: 7737627 DOI: 10.1016/0270-9139(95)90041-1]
72. Bresci G, Gambardella L, Parisi G, Federici G, Bertini M, Rindi G, Metrangolo S, Tumino E, Bertoni M, Cagno MC, Capria A. Colonic disease in cirrhotic patients with portal hypertension: an endoscopic and clinical evaluation. J Clin Gastroenterol 1998; 26: 222-227 [PMID: 9600375 DOI: 10.1097/00004836-199804000-00016]
73. Misra SP, Misra V, Dwivedi M. Effect of esophageal variceal band ligation on hemorrhoids, anorectal varices, and portal hypertensive colopathy. Endoscopy 2002; 34: 195-198 [PMID: 11870568 DOI: 10.1055/s-2002-20290]
74. Ito K, Shiraki K, Sakai T, Yoshimura H, Nakano T. Portal hypertensive colopathy in patients with liver cirrhosis. World J Gastroenterol 2005; 11: 3127-3130 [PMID: 15918202 DOI: 10.3748/wjg.v11.i20.3127]
75. Yamakado S, Kanazawa H, Kobayashi M. Portal hypertensive colopathy: endoscopic findings and the relation to portal pressure. Intern Med 1995; 34: 153-157 [PMID: 7787318 DOI: 10.2169/internalmedicine.34.153]
76. Scandalis N, Archimandritis A, Kastanas K, Spiliadis C, Delis B, Manika Z. Colonic findings in cirrhotics with portal hypertension. A prospective colonoscopic and histological study. J Clin Gastroenterol 1994; 18: 325-328; discussion 329 [PMID: 8071520 DOI: 10.1097/00004836-199406000-00014]
77. Chawla Y, Dilawari JB. Anorectal varices--their frequency in cirrhotic and non-cirrhotic portal hypertension. Gut 1991; 32: 309-311 [PMID: 2013427 DOI: 10.1136/gut.32.3.309]
78. Rabinovitz M, Schade RR, Dindzans VJ, Belle SH, Van Thiel DH, Gavaler JS. Colonic disease in cirrhosis. An endoscopic evaluation in 412 patients. Gastroenterology 1990; 99: 195-199 [PMID: 2344925]
79. Goenka MK, Kochhar R, Nagi B, Mehta SK. Rectosigmoid varices and other mucosal changes in patients with portal hypertension. Am J Gastroenterol 1991; 86: 1185-1189 [PMID: 1882798]
80. Yeşilkaya Y, Çil B, Peynircioğlu B, Şimşek H. Successful treatment with transjugular intrahepatic portosystemic shunt (TIPS) of recurrent massive rectal bleeding due to portal hypertension: case report. Turk J Gastroenterol 2013; 24: 363-366 [PMID: 24254271]
81. Wilson SE, Stone RT, Christie JP, Passaro E. Massive lower gastrointestinal bleeding from intestinal varices. Arch Surg 1979; 114: 1158-1161 [PMID: 314792 DOI: 10.1001/archsurg.1979.01370340064011]
82. Bini EJ, Lascarides CE, Micale PL, Weinshel EH. Mucosal abnormalities of the colon in patients with portal hypertension: an endoscopic study. Gastrointest Endosc 2000; 52: 511-516 [PMID: 11023569 DOI: 10.1067/mge.2000.108478]
83. Sugano S, Nishio M, Makino H, Suzuki T. Relationship of portal pressure and colorectal vasculopathy in patients with cirrhosis. Dig Dis Sci 1999; 44: 149-154 [PMID: 9952236 DOI: 10.1023/A:1026670604551]
84. Gad YZ, Zeid AA. Portal hypertensive colopathy and haematochezia in cirrhotic patients: an endoscopic study. Arab J Gastroenterol 2011; 12: 184-188 [PMID: 22305498 DOI: 10.1016/j.ajg.2011.11.002]
85. Johal SS, Austin AS, Ryder SD. Epistaxis: an overlooked cause of massive haematemesis in cirrhosis. BMJ 2003; 326: 440-441 [PMID: 12595387 DOI: 10.1136/bmj.326.7386.440]
86. Abouelalaa K, Nadaud J, Caumes D, Esnaut P, Favier JC. [Haemorrhagic shock following a dental bleeding in a cirrhotic patient]. Ann Fr Anesth Reanim 2007; 26: 714-715 [PMID: 17572040 DOI: 10.1016/j.annfar.2007.03.028]
87. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430 [PMID: 11592607 DOI: 10.1016/S0168-8278(01)00130-1]
88. Sotiropoulos GC, Radtke A, Schmitz KJ, Molmenti EP, Schroeder T, Saner FH, Baba HA, Fouzas I, Broelsch CE, Malagó M, Lang H. Liver transplantation in the setting of hepatocellular carcinoma and portal vein thrombosis: a challenging dilemma? Dig Dis Sci 2008; 53: 1994-1999 [PMID: 18080191 DOI: 10.1007/s10620-007-0099-4]
89. Rodríguez-Castro KI, Porte RJ, Nadal E, Germani G, Burra P, Senzolo M. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation 2012; 94: 1145-1153 [PMID: 23128996 DOI: 10.1097/TP.0b013e31826e8e53]
90. Yerdel MA, Gunson B, Mirza D, Karayalçin K, OlliffS, Buckels J, Mayer D, McMaster P, Pirenne J. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000; 69: 1873-1881 [PMID: 10830225 DOI: 10.1097/00007890-200005150-00023]
91. Egawa H, Tanaka K, Kasahara M, Takada Y, Oike F, Ogawa K, Sakamoto S, Kozaki K, Taira K, Ito T. Single center experience of 39 patients with preoperative portal vein thrombosis among 404 adult living donor liver transplantations. Liver Transpl 2006; 12: 1512-1518 [PMID: 17004256 DOI: 10.1002/lt.20777]
92. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, Lancellotti S, Santoliquido A, Flore R, Pompili M, Rapaccini GL, Tondi P, Gasbarrini GB, LandolfiR, Gasbarrini A. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51: 682-689 [PMID: 19464747 DOI: 10.1016/j.jhep.2009.03.013]
93. Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005; 54: 691-697 [PMID: 15831918 DOI: 10.1136/gut.2004.042796]
94. Martinelli I. von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis. Semin Hematol 2005; 42: 49-55 [PMID: 15662616 DOI: 10.1053/j.seminhematol.2004.09.009]
95. Fimognari FL, De Santis A, Piccheri C, Moscatelli R, Gigliotti F, Vestri A, Attili A, Violi F. Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. J Lab Clin Med 2005; 146: 238-243 [PMID: 16194685 DOI: 10.1016/j.lab.2005.06.003]
96. Martinelli I, Primignani M, Aghemo A, Reati R, Bucciarelli P, Fabris F, Battaglioli T, Dell'Era A, Mannucci PM. High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol 2009; 50: 916-922 [PMID: 19304336 DOI: 10.1016/j.jhep.2008.12.020]
97. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40: 736-741 [PMID: 15094219 DOI: 10.1016/j.jhep.2004.01.001]
98. Nery F, Chevret S, Condat B, de Raucourt E, Boudaoud L, Rautou PE, Plessier A, Roulot D, Chaffaut C, Bourcier V, Trinchet JC, Valla DC. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology 2015; 61: 660-667 [PMID: 25284616 DOI: 10.1002/hep.27546]
99. Girleanu I, Stanciu C, Cojocariu C, Boiculese L, Singeap AM, Trifan A. Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients. Saudi J Gastroenterol 2014; 20: 288-292 [PMID: 25253363 DOI: 10.4103/1319-3767.141687]
100. Northup PG, McMahon MM, Ruhl AP, Altschuler SE, Volk-Bednarz A, Caldwell SH, Berg CL. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006; 101: 1524-1528; quiz 1680 [PMID: 16863556 DOI: 10.1111/j.1572-0241.2006.00588.x]
101. Huerta C, Johansson S, Wallander MA, García Rodríguez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 2007; 167: 935-943 [PMID: 17502535 DOI: 10.1001/archinte.167.9.935]
102. Søgaard KK, Horváth-Puhó E, Grønbaek H, Jepsen P, Vilstrup H, Sørensen HT. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009; 104: 96-101 [PMID: 19098856 DOI: 10.1038/ajg.2008.34]
103. García-Fuster MJ, Abdilla N, Fabiá MJ, Fernández C, Oliver V. [[]Venous thromboembolism and liver cirrhosis]. Rev Esp Enferm Dig 2008; 100: 259-262 [PMID: 18662076 DOI: 10.4321/S1130-01082008000500002]
104. Gulley D, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci 2008; 53: 3012-3017 [PMID: 18443906 DOI: 10.1007/s10620-008-0265-3]
105. Ali M, Ananthakrishnan AN, McGinley EL, Saeian K. Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci 2011; 56: 2152-2159 [PMID: 21279685 DOI: 10.1007/s10620-011-1582-5]
106. Wu H, Nguyen GC. Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin Gastroenterol Hepatol 2010; 8: 800-805 [PMID: 20566312 DOI: 10.1016/j.cgh.2010.05.014]
107. Intagliata NM, Henry ZH, Shah N, Lisman T, Caldwell SH, Northup PG. Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding. Liver Int 2014; 34: 26-32 [PMID: 23758818 DOI: 10.1111/liv.12211]
108. Rodriguez-Castro KI, Simioni P, Burra P, Senzolo M. Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis. Liver Int 2012; 32: 1465-1476 [PMID: 22734713 DOI: 10.1111/j.1478-3231.2012.02839.x]
109. Rodriguez-Castro KI. Anticoagulation for portal vein thrombosis in cirrhosis - Response to Naeshiro and collaborators. Hepatol Res 2015; Epub ahead of print [PMID: 25594445 DOI: 10.1111/hepr.12491]